OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)

KIDS 12.02.2024

Full Press ReleaseSEC FilingsOur KIDS Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
  • 01.13.2025 - OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
  • 01.10.2025 - OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division

Recent Filings

  • 01.14.2025 - EX-99.1 EX-99.1
  • 01.14.2025 - 8-K Current report
  • 12.30.2024 - 4 Statement of changes in beneficial ownership of securities
Continues IPOS Corporate Partnership as Emerald-Level Sponsor

WARSAW, Ind.,Dec. 02, 2024(GLOBE NEWSWIRE) --OrthoPediatrics Corp.(“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its continued support of the event as an Emerald-Level sponsor. IPOS, a branch of thePediatric Orthopedic Society of North America(POSNA), is a leading educational meeting for pediatric orthopedic surgeons. Over500pediatric orthopedic surgeons are registered to attend the meeting fromDecember 3-7, inOrlando, Florida.

“This year marks the 20thAnnual IPOS meeting, and I couldn’t be prouder of our partnership with this surgical society, and our participation in this meeting,” saidDavid Bailey, President and CEO ofOrthoPediatrics. “IPOS is a great educational opportunity for early career surgeons, and our team is excited to connect with customers and share hands-on learning experiences with our new and innovative products. I’m especially excited to introduce our new Enabling Technology division as well as highlight all the great work we are doing in non-operative care through OPSB Specialty Bracing.”

In addition to the exhibition booths (#1 - 3), wherein the Company will highlight their full suite of products, and feature its new Enabling Technology division with 7D, 3-D Side and the new Specialty Bracing division (OPSB), the Company is hosting several educational experiences for surgeons and other allied health professionals. OrthoPediatrics IPOS 2024 Events include:

Pre-course

  • Innovation – Bringing Creative Solutions from Ideas to RealityTuesday, December 3, 2024, 6:30 –7:45pm ET

Industry Spotlight Sessions

  • Rigid Tibial Nailing in the Skeletally Immature Patient: What We’ve Learned So FarWednesday, December 4, 2024,10:35am ET
  • The Future is Bioresorbable: Innovative Implant Materials in PediatricsWednesday, December 4, 2024,4:05pm ET
  • Launching Your Surgical Career: Essential Steps to Start StrongWednesday, December 4, 2024,4:05pm ET
  • Is it Possible to Minimize Spica Cast Usage?Thursday, December 5, 2024,10:35am ET

AboutOrthoPediatrics Corp.Founded in 2006,OrthoPediatricsis an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions.OrthoPediatricscurrently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products inthe United Statesand over 70 countries outsidethe United States. For more information, please visitwww.orthopediatrics.com.

Investor ContactPhilip Trip TaylorGilmartin Groupphilip@gilmartinir.com415-937-5406

Primary Logo

Source: OrthoPediatrics Corp.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com